Nephros Inc.

191 articles with Nephros Inc.

• Nephros Receives FDA 510(k) Clearance for HDF Assist Module

  5/17/2022

  The First and Only FDA-Cleared Device Available in the United States to Provide Hemodiafiltration Therapy to Dialysis Patients.

• Nephros Announces Results for Quarter Ended March 31, 2022

  5/4/2022

  Nephros, Inc. announced financial results for the first quarter ended March 31, 2022.

• Nephros First Quarter 2022 Financial Results Conference Call

  4/27/2022

  Nephros, Inc. today announced that it will file its first-quarter financial results on Wednesday, May 4, 2022 after market close and will host a conference call that same day at 4:30 PM ET.

• Nephros to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

  3/21/2022

  Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced that Andy Astor, Chief Executive Officer of Nephros, will be presenting at the 2022 Virtual Growth Conference.

• Nephros Announces Fourth Quarter and Fiscal Year 2021 Financial Results

  2/23/2022

  Nephros, Inc., a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, announced financial results for the fourth quarter and fiscal year ended December 31, 2021.

• Nephros Fourth Quarter 2021 Financial Results Conference Call

  2/9/2022

  Nephros, Inc. today announced that it will file its fourth quarter financial results on Wednesday, February 23, 2022 after market close and will host a conference call that same day at 4:30 PM ET.

• Nephros Issues 2022 Shareholder Letter

  1/13/2022

  Nephros, Inc today issued a 2022 letter to shareholders.

• Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2021 and Revenue Guidance for 2022

  1/11/2022

  Nephros, Inc. today announced preliminary results for the fiscal year ended December 31, 2021.

• Nephros Announces Results for Quarter Ended September 30, 2021

  11/4/2021

  Nephros, Inc., a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, announced results for the three months ended September 30, 2021.

• Nephros Announces Third Quarter 2021 Financial Results Conference Call

  10/21/2021

  Nephros, Inc. today announced that it will file its third quarter financial results on Thursday, November 4, 2021 after market close and will host a conference call that same day at 4:30 PM ET.

• Nephros Announces Preliminary Results for Third Quarter of 2021

  10/8/2021

  Nephros, Inc. today announced preliminary results for the third quarter of 2021.

• Nephros to Present at the LD Micro Main Event

  10/5/2021

  Nephros, Inc. today announced it has been selected to present at the  14th  Annual LD Micro Main Event  on Tuesday, October 12, 2021 at 12:30 pm ET at the Luxe Sunset Bel-Air in Los Angeles.

• Nephros to Present at the Virtual MicroCap Leadership Summit

  9/15/2021

  Nephros, Inc. today announced it has been selected to present at the 6th annual  MicroCap Leadership Summit on Friday, September 24th, 2021.

• Nephros Appoints Wes Lobo to Chief Commercial Officer

  9/1/2021

  Nephros, Inc. today announced the appointment of Wes Lobo to the role of Chief Commercial Officer.

• Nephros Announces Results for Quarter Ended June 30, 2021

  8/5/2021

  Nephros, Inc., a leading biotechnology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, announced results for the three months ended June 30, 2021.

• Nephros Announces Acquisition of GenArraytion, Inc.

  7/12/2021

  Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it has acquired substantially all of the assets of Rockville, MD-based GenArraytion, Inc.

• Nephros CEO Presenting at Access to Giving Virtual Investor Conference

  7/9/2021

  via NewMediaWire – Nephros, Inc., a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, has been invited to present at the Access to Giving Virtual Investor conference, which is being held July 13-15.

• Nephros Announces Preliminary Results for Second Quarter of 2021

  7/8/2021

  Nephros, Inc. today announced preliminary results for the second quarter of 2021.

• Nephros Announces Results for Quarter Ended March 31, 2021

  5/6/2021

  Nephros, Inc., a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, announced results for the three months ended March 31, 2021.

• Nephros Announces First Quarter 2021 Financial Results Conference Call

  4/26/2021

  Nephros , Inc. (Nasdaq: NEPH), a leading water technology company, today announced that it will file its first quarter financial results on Thursday, May 6, 2021 after market close and will host a conference call that same day at 4:30 PM ET.